536565 TRIMURTHI

Novelix Pharmaceuticals Share Price

 

Stock Result Declared

 

Start SIP in TRIMURTHI

Start SIP

Performance

  • Low
  • ₹62
  • High
  • ₹63
  • 52 Week Low
  • ₹25
  • 52 Week High
  • ₹70
  • Open Price₹63
  • Previous Close₹61
  • Volume1,251
  • 50 DMA₹58.45
  • 100 DMA₹54.24
  • 200 DMA₹45.62

Investment Returns

  • Over 1 Month + 12.46%
  • Over 3 Month + 12.24%
  • Over 6 Month + 52.2%
  • Over 1 Year + 148.09%

Smart Investing Starts Here Start SIP with Novelix Pharmaceuticals for Steady Growth!

Invest Now

Novelix Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 60.6
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 111
  • P/B Ratio
  • 3.9
  • Average True Range
  • 3.69
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.01
  • RSI
  • 54.44
  • MFI
  • 63.81

Novelix Pharmaceuticals Financials

Novelix Pharmaceuticals Technicals

EMA & SMA

Current Price
₹62.89
+ 1.6 (2.61%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹60.41
  • 50 Day
  • ₹58.45
  • 100 Day
  • ₹54.24
  • 200 Day
  • ₹45.62

Resistance and Support

60.93 Pivot Speed
  • R3 68.46
  • R2 65.83
  • R1 63.56
  • S1 58.66
  • S2 56.03
  • S3 53.76

Novelix Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2025-11-13 Quarterly Results
2025-08-14 Quarterly Results & A.G.M.
2025-06-24 Others Inter alia, to consider and approve 1. The conversion of Warrants into Equity Shares of the Company.
2025-05-27 Audited Results

Novelix Pharmaceuticals F&O

Novelix Pharmaceuticals Shareholding Pattern

50.8%
44%
5.2%

Novelix Pharmaceuticals FAQs

Novelix Pharmaceuticals share price is ₹62 As on 13 February, 2026 | 13:29

The Market Cap of Novelix Pharmaceuticals is ₹110.8 Cr As on 13 February, 2026 | 13:29

The P/E ratio of Novelix Pharmaceuticals is 60.6 As on 13 February, 2026 | 13:29

The PB ratio of Novelix Pharmaceuticals is 3.9 As on 13 February, 2026 | 13:29

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23